TD Cowen has upgraded CRISPR Therapeutics (CRSP) to hold from sell, stating it now sees less downside to the stock. Read more ...
TD Cowen analyst William Katz maintained a Hold rating on Artisan Partners (APAM – Research Report) today and set a price target of $46.00. The ...
TD Cowen analyst William Katz maintained a Hold rating on Carlyle Group (CG – Research Report) today and set a price target of $54.00. The ...
TD Cowen analysts made adjustments to the stock of Fidelity National Information Services (NYSE:FIS), reducing the price target to $81 from the previous $87 while maintaining a Hold rating on the ...
TD Cowen had upgraded Merck in early 2024 based on confidence in Keytruda and Gardasil’s performance, a lack of binary risks, and an attractive valuation. However, setbacks in Gardasil’s China sales ...
We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...
Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its ...
DeepSeek has quickly gained attention in AI with its R1 model, which delivers high performance at a lower cost.
Teledyne Technologies Incorporated (NYSE:TDY) today announced that George Bobb, President and Chief Operating Officer, and Jason VanWees, Vice Chairman, will present at the TD Cowen 46th Annual ...
Investing.com -- TD Cowen downgraded Illumina Inc (NASDAQ:ILMN) to "Hold" following the company's fourth-quarter earnings, citing weaker-than-expected next-generation sequencing (NGS) consumable ...